当前位置:首页 - 行情中心 - 恒瑞医药(600276) - 财务分析

恒瑞医药

(600276)

  

流通市值:4534.83亿  总市值:4718.39亿
流通股本:63.79亿   总股本:66.37亿

恒瑞医药(600276)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润44.55亿元,每股收益0.70元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益5902979.80万元,未分配利润3704150.52万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产6289351.71万元,负债386371.91万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入15,761,193,628.97,205,611,122.7227,984,605,342.0620,189,303,845.1
营业总成本10,900,173,954.425,134,690,588.221,008,000,532.0315,089,979,241.8
其他经营收益
营业利润5,158,892,665.212,085,980,911.667,490,632,003.885,345,290,528.73
利润总额5,050,934,208.952,075,603,711.837,169,689,995.755,086,740,155.23
净利润4,454,670,657.211,876,441,961.326,336,994,647.534,616,330,177.46
每股收益
其他综合收益26,151,612.622,346,805.44-624,026.11-12,630,993.15
综合收益总额4,480,822,269.831,878,788,766.766,336,370,621.424,603,699,184.31
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计46,760,288,804.8835,969,765,897.935,314,927,240.5934,456,969,388.16
非流动资产:
非流动资产合计16,133,228,343.6615,323,015,793.0114,820,718,063.5113,881,130,024.56
资产总计62,893,517,148.5451,292,781,690.9150,135,645,304.148,338,099,412.72
流动负债:
流动负债合计3,465,048,543.013,362,881,494.13,633,595,722.673,829,566,410.17
非流动负债:
非流动负债合计398,670,566.39380,131,139.07411,798,848.12177,014,307.13
负债合计3,863,719,109.43,743,012,633.174,045,394,570.794,006,580,717.3
所有者权益(或股东权益):
归属于母公司股东权益合计58,464,831,216.7846,987,059,491.0845,519,861,860.3243,767,908,821.75
股东权益合计59,029,798,039.1447,549,769,057.7446,090,250,733.3144,331,518,695.42
负债和股东权益合计62,893,517,148.5451,292,781,690.9150,135,645,304.148,338,099,412.72
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计16,123,794,040.476,301,936,538.2928,468,881,744.1320,546,797,062.7
经营活动现金流出小计11,823,340,789.075,746,762,449.7821,046,128,705.4215,961,351,053.58
经营活动产生的现金流量净额4,300,453,251.4555,174,088.517,422,753,038.714,585,446,009.12
投资活动产生的现金流量:
投资活动现金流入小计182,832,015.64170,354,321.21679,892,183.13251,221,022.45
投资活动现金流出小计1,267,564,947.42702,031,901.522,591,877,899.362,124,667,512.24
投资活动产生的现金流量净额-1,084,732,931.78-531,677,580.31-1,911,985,716.23-1,873,446,489.79
筹资活动产生的现金流量:
筹资活动现金流入小计10,351,937,892.28-799,909,380.08799,909,380.08
筹资活动现金流出小计2,312,442,891.87661,059,213.922,350,499,405.962,306,433,430.14
筹资活动产生的现金流量净额8,039,495,000.41-661,059,213.92-1,550,590,025.88-1,506,524,050.06
汇率变动对现金及现金等价物的影响48,287,663.4729,624,153.667,400,551.34-21,219,513.59
现金及现金等价物净增加额11,303,502,983.5-607,938,552.063,967,577,847.941,184,255,955.68
期末现金及现金等价物余额35,542,605,101.1623,631,163,565.624,239,102,117.6621,455,780,225.4
补充资料:
现金及现金等价物的净增加额11,303,502,983.5-3,967,577,847.94-
最新报告期:2025-09-15
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
天风证券杨松,曹文清1.361.491.772025-09-15
群益证券王睿哲1.521.371.572025-09-05
西南证券杜向阳1.061.321.592025-09-02
中信证券陈竹1.341.651.982025-08-28
中银证券刘恩阳1.001.201.402025-08-28
TOP↑